| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 1.733.586 | 3.320.692 | 3.383.572 | 3.241.454 | 3.658.789 |
| Total Income - EUR | - | - | - | - | 0 | 1.738.379 | 3.328.838 | 3.403.651 | 3.265.644 | 3.666.937 |
| Total Expenses - EUR | - | - | - | - | 3 | 1.592.624 | 3.288.957 | 3.393.231 | 3.375.291 | 3.713.721 |
| Gross Profit/Loss - EUR | - | - | - | - | -3 | 145.755 | 39.882 | 10.420 | -109.646 | -46.784 |
| Net Profit/Loss - EUR | - | - | - | - | -3 | 111.547 | 30.341 | 10.420 | -109.646 | -46.784 |
| Employees | - | - | - | - | 0 | 25 | 31 | 34 | 31 | 32 |
Check the financial reports for the company - Angiocare S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 24 | 667.638 | 662.189 | 949.407 | 879.441 | 860.563 |
| Current Assets | - | - | - | - | 1.052 | 217.881 | 214.951 | 315.369 | 308.863 | 215.992 |
| Inventories | - | - | - | - | 0 | 105.839 | 102.191 | 110.757 | 91.377 | 79.531 |
| Receivables | - | - | - | - | 0 | 32.810 | 32.562 | 79.371 | 113.993 | 124.585 |
| Cash | - | - | - | - | 1.052 | 79.233 | 80.199 | 125.241 | 103.493 | 11.876 |
| Shareholders Funds | - | - | - | - | 1.050 | 112.577 | 140.474 | 202.916 | 92.655 | 70.042 |
| Social Capital | - | - | - | - | 1.054 | 1.034 | 1.011 | 1.014 | 1.011 | 1.005 |
| Debts | - | - | - | - | 26 | 762.504 | 721.572 | 1.064.315 | 1.098.800 | 1.009.286 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Angiocare S.r.l.